Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Page now reflects a new software/operational revision (v3.2.0) and includes a government-funding status notice, replacing the previous v3.1.0 and its associated wording.
    Difference
    2%
    Check dated 2025-10-04T04:28:23.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-27T02:17:27.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The item/service availability has been reversed from Available to No longer available, indicating it is no longer offered.
    Difference
    0.1%
    Check dated 2025-09-19T23:21:33.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Standardizes regional naming to 'Tatarstan, Respublika' and updates the Kazan address accordingly (v3.0.2); removes the 'Back to Top' link as a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-12T17:29:09.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T14:07:46.000Z thumbnail image
  9. Check
    60 days ago
    Change Detected
    Summary
    The webpage has been updated with new facility names and locations, including specific cities and countries, as well as a new publication related to telisotuzumab vedotin. Additionally, the page now includes a new date for an estimated last update.
    Difference
    27%
    Check dated 2025-08-29T10:45:22.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.